The authors are in the Inflammation Department, Experimental Medicine Division, Millennium Pharmaceuticals, Cambridge, Massachusetts 02139, USA. coyle@mpi.com or gutierrez@mpi.com
The identification of BLTA and its ligand B7x adds to the growing list of negative costimulatory molecules that can dampen the adaptive immune response.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
